Andy Gillespie

635 total citations
13 papers, 468 citations indexed

About

Andy Gillespie is a scholar working on Neurology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Andy Gillespie has authored 13 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 5 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Andy Gillespie's work include Cancer therapeutics and mechanisms (5 papers), Neurofibromatosis and Schwannoma Cases (5 papers) and Neuroblastoma Research and Treatments (4 papers). Andy Gillespie is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Neurofibromatosis and Schwannoma Cases (5 papers) and Neuroblastoma Research and Treatments (4 papers). Andy Gillespie collaborates with scholars based in United States and Ukraine. Andy Gillespie's co-authors include Frank M. Balis, Gregory H. Reaman, Roger J. Packer, Richard L. Heideman, Diane E. Cole, Peter C. Adamson, Stacey L. Berg, Brigitte C. Widemann, Susan M. Blaney and David G. Poplack and has published in prestigious journals such as Journal of Clinical Oncology, Developmental Medicine & Child Neurology and Cancers.

In The Last Decade

Andy Gillespie

13 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andy Gillespie United States	9	214	213	149	143	93	13	468
Cormac Owens Ireland	12	221 1.0×	117 0.5×	107 0.7×	37 0.3×	130 1.4×	40	419
T. Holbrook United States	10	252 1.2×	192 0.9×	137 0.9×	31 0.2×	184 2.0×	13	551
JM Zucker France	6	70 0.3×	155 0.7×	84 0.6×	41 0.3×	52 0.6×	10	310
R. N. HITCHINS United Kingdom	7	72 0.3×	298 1.4×	203 1.4×	174 1.2×	40 0.4×	11	438
Marie‐Laure Brisson Canada	10	73 0.3×	90 0.4×	47 0.3×	67 0.5×	73 0.8×	11	308
Amy Watkins United Kingdom	10	88 0.4×	145 0.7×	83 0.6×	25 0.2×	124 1.3×	17	405
Jana Obertová Slovakia	12	85 0.4×	149 0.7×	155 1.0×	42 0.3×	164 1.8×	69	506
Henry T. Quach United States	8	80 0.4×	152 0.7×	502 3.4×	89 0.6×	87 0.9×	12	625
Ayşe Nur Demiral Türkiye	13	44 0.2×	197 0.9×	141 0.9×	33 0.2×	68 0.7×	31	402
Pauline Laly France	8	79 0.4×	75 0.4×	350 2.3×	88 0.6×	75 0.8×	16	460

Countries citing papers authored by Andy Gillespie

Since Specialization

Citations

This map shows the geographic impact of Andy Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Gillespie more than expected).

Fields of papers citing papers by Andy Gillespie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Gillespie. The network helps show where Andy Gillespie may publish in the future.

Co-authorship network of co-authors of Andy Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Gillespie. A scholar is included among the top collaborators of Andy Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Gillespie. Andy Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Toledo‐Tamula, Mary Anne, Staci Martin, Andy Gillespie, et al.. (2024). Written language achievement in children and adolescents with neurofibromatosis type 1 and Plexiform Neurofibromas. Child Neuropsychology. 30(7). 1095–1115. 1 indexed citations

Hou, Yang, Taryn Allen, Mary Anne Toledo‐Tamula, et al.. (2023). Longitudinal association between executive function and academic achievement in children with neurofibromatosis type 1 and plexiform neurofibromas. Journal of the International Neuropsychological Society. 29(9). 839–849. 5 indexed citations

Hou, Yang, Dan Liu, Staci Martin, et al.. (2022). Demographic and Disease-Related Predictors of Socioemotional Development in Children with Neurofibromatosis Type 1 and Plexiform Neurofibromas: An Exploratory Study. Cancers. 14(23). 5956–5956. 5 indexed citations

Torres, Madeline B., Laurence P. Diggs, Jun S. Wei, et al.. (2021). Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma. Cancer Genetics. 256-257. 21–25. 1 indexed citations

Hou, Yang, Taryn Allen, Pamela L. Wolters, et al.. (2020). Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas. Developmental Medicine & Child Neurology. 62(8). 977–984. 14 indexed citations

Kahn, Jenna M., Andy Gillespie, Maria Tsokos, et al.. (2014). Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. Frontiers in Oncology. 4. 324–324. 90 indexed citations

Adamson, Peter C., Susan M. Blaney, Brenda J. Kitchen, et al.. (2004). Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101. Cancer Chemotherapy and Pharmacology. 53(6). 482–488. 25 indexed citations

Blaney, Susan M., Richard L. Heideman, Stacey L. Berg, et al.. (2002). Phase I Clinical Trial of Intrathecal Topotecan in Patients With Neoplastic Meningitis. Journal of Clinical Oncology. 21(1). 143–147. 74 indexed citations

Blaney, Susan M., Michael N. Needle, Andy Gillespie, et al.. (1998). Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.. PubMed. 4(2). 357–60. 51 indexed citations

10.

Adamson, Peter C., Frank M. Balis, J. Miser, et al.. (1992). Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.. PubMed. 52(3). 521–4. 27 indexed citations

11.

Berg, Stacey L., Frank M. Balis, Solomon Zimm, et al.. (1992). Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.. Journal of Clinical Oncology. 10(1). 143–148. 46 indexed citations

12.

Balis, Frank M., et al.. (1990). Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule.. PubMed. 50(15). 4464–7. 18 indexed citations

13.

Heideman, Richard L., Diane E. Cole, Frank M. Balis, et al.. (1989). Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa.. PubMed. 49(3). 736–41. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact